Monterrey Plant

Monterrey Plant
Marco Stevanato, Vice President Special Projects
Stevanato Group is the world’s largest
privately owned designer and provider of
glass parenteral packaging for the
pharmaceutical industry
From the outset, Stevanato Group has been
self-sufficient in developing the necessary
technology and machinery required to
ensure the highest standards of quality and
innovation throughout the production
process.
2
Mission
To create systems and
processes that guarantee
the integrity of parenteral
medicines.
3
Stevanato Group in brief
+65
2
7
Over 65
years of
experience
2 Operative Divisions
(Pharmaceutical and
Engineering systems)
7 Manufacturing
Sites
4
Stevanato Group Company and Brand Structure
PHARMACEUTICAL
SYSTEMS
ENGINEERING
SYSTEMS
CONVERTING
SYSTEMS
PHARMA
INSPECTION
SYSTEMS
5
Structured Flexibility
6
Stevanato Group Today
Brabrand
Bratislava
Newtown, PA | Sales Office
Zhangjiagang
Monterrey
Piombino Dese
Piombino Dese
Piombino Dese
Latina
Zhangjiagang | Sales Office
Piombino Dese | Headquaters
7
EZ-FILL SYRINGES
New Sterile Department
INNOSCAN
Acquisition
ZHANGJIAGANG PLANT
Trade office | Foundation stone
MONTERREY PLANT
Doubling of the Plant
EZ-FILL VIALS
CARTRIDGES
New Sterile Department
2007
MONTERREY PLANT
Opening
EZ-FILL SYRINGE
Sterile Department
1949 1971 1993 2005
OPTREL
Acquisition
BRATISLAVA PLANT
Medical Glass Acquisition
LATINA PLANT
Alfamatic Acquisition
SPAMI
Foundation
STEVANATO GROUP
OMPI Foundation
Company Milestones
2008 2010 2011 2012 2013 2014
8
Key Figures
NET SALES (in MM Euro)
KEY FIGURES
290*
CAGR 2013/1998:
+15%
EXPORT
>90%
For Italian Plants
EMPLOYEES
~1900
Pharma
systems
84%
240
208
188
16%
174
2010
2011
2012
2013
2014
[*BUDGET]
Engineering
9
Investments
INVESTMENTS (in MM Euro)
31
18
2011
2012
Investment (% of net sales)
11%
4%
Technology,
quality, training
Research
48
44
2013
2014
Main Area of Investment (2014)
Ompi of China
plant
Ompi EZ-fill
plant
New syringe
department
10
Our Strategy
Clear market differentiation
Increased worldwide presence
Excellence in quality
Growth in new markets
Continuous innovation
New manufacturing sites
New added value products
New sales offices
11
The Key elements of our Industrial Plan
Our Mission: To create systems and processes that guarantee the integrity of
parenteral medicines.
PHARMACEUTICAL MARKET
NEW PRODUCTS
DEVELOPMENT
INNOSCAN
OPTREL
SPAMI
ADDED VALUE SOLUTIONS
NEW
ACQUISITIONS
OTHER ADDED VALUE SYSTEMS
ADDED VALUE COMPONENTS AND SYSTEM INTEGRATION
DELIVERY DEVICES AND SUPPORTING SYSTEMS
OMPI EZ-FILL | READY-TO-USE GLASS CONTAINERS
OMPI ALBA | BREAKTHROUGH SOLUTIONS
OMPI FINA, OMPI NEXA |
ITALY
SLOVAKIA
OPTIMIZED PACKAGING FOR PARENTERALS
MEXICO
CHINA
Pharmaceutical Systems Division Growth
Engineering Systems Division Growth
GLOBAL
TECHNOLOGICAL
LEADERSHIP
NEW
GLOBAL EXPANSION
12
Monterrey Plant: Target
LOGIC OF
INTERNATIONALIZATION
AND NOT
DELOCALIZATION:
Support our MAIN
PHARMACEUTICAL
CUSTOMERS of the
Americas with a LOCAL
SOURCE providing the
WORLD-CLASS
PRODUCTS they were
used to receive from
NUOVA OMPI
13
Monterrey: Pros
•Mexico’s leading industrial
economy is in Monterrey
•World-class bilingual technical
education (among highest technical
University concentration within
Mexico)
•Consolidated presence of highquality glass converter recognized
from the pharmaceutical industries
•Ideal location to serve both Nord
and South America through a
modern and efficient logistic
network (road – sea – air)
14
Monterrey Plant: Timeline
Products approval
Supply from EU plant
NAFTA Distribution Center
2013
Building expansion completed (Phase II)
2011
Start-up of ampoules dept.
2010
Installation of first lines (cartridges and vials)
Start-up
Stability and validation
2008
Construction of building (phase I)
Personnel selection
1st batch training in NO
2007
Feasibility study
Location analysis
Customers commitment
Products approval
Supply from EU plant
NAFTA Distribution Center
15
Monterrey Plant: Phase 1 and Phase 2
Warehouse
Technical
areas
Phase 1
Offices
Phase 2
Property: 45.000 square feet
A Phase III is planned for the future
Phase 1
Phase 2
Dimensions (square
meters)
6000
6000
Investments
(Mio Eur)
18-22
18-22
16
Monterrey Plant: Update
June 2007
Sept 2007
Oct 2008
June 2011
June 2012
17
Mexico: Tips from our experience
•Need to select the management
properly (“tropicalization” problem)
and to provide the right control
from the HQ
•The presence on site of someone
with decisional power is absolutely
necessary during the start up
phase
•Importance of creating the right
mix between local employees and
expatriates
•Tax and fiscal area to be carefully
monitored
•Need to carefully organize staff
training
18
Thank you for your attention!

Download Report